A recent Harvard study found that the Covid-19 vaccine might actually be more dangerous than the virus it’s supposed to fight against.
The booster shot that supposedly targets the Omicron variant has only been tested on 8 mice. According to Fauci, there is “no time” to do clinical trials. “It hasn’t been proven in a clinical trial, because we don’t have time to do a clinical trial because we need to get the vaccine out now.” He continues, “we have such a situation throughout the world and certainly in the United States, we’re having 400 deaths per day and up to 5,000 hospitalizations a day.” Rochelle Walensky, CDC Director, parroted Fauci’s concerns by stating that “consequences could be worse” if we wait.
This month, scientists from Harvard and Johns Hopkins University found that the risks greatly outweigh the benefits when it comes to the boosters. Supposedly, the adverse effects could be up to 98% worse than getting hospitalized for the virus it’s supposed to fight against. The published paper found “that booster mandates may cause a net expected harm: per COVID-19 hospitalisation prevented in previously uninfected young adults, we anticipate 18 to 98 serious adverse events.” The paper also mentions that some of the recipients received myocarditis and other severe reactions that interfered with their daily activities. The article states that the “University booster mandates are unethical” due to the harm that it's causing to young people. As of today, an estimated 108 million individuals have already received their boosters.
Back in 1976, the government also pushed for an understudied vaccine that inoculated millions of Americans against the Swine Flu, only for them to realize later on that there wasn't even a pandemic. Some of the recipients developed a rare neurological disorder called Guillain-Barré syndrome, with other news reports claiming the shot resulted in deaths. 46 years later, it seems that the government hasn't learned from past mistakes.
Like our take on current events? Sign up for our free daily news newsletter, The Glance.